Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $61.05 | 1 | 73.7% |
| Food and Beverage | $21.79 | 1 | 26.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $61.05 | 1 | $0 (2019) |
| Janssen Global Services, LLC | $21.79 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $21.79 | 1 | Janssen Global Services, LLC ($21.79) |
| 2019 | $61.05 | 1 | Gilead Sciences, Inc. ($61.05) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2023 | Janssen Global Services, LLC | — | Food and Beverage | In-kind items and services | $21.79 | General |
| 04/30/2019 | Gilead Sciences, Inc. | — | — | Cash or cash equivalent | $61.05 | Research |
| Study: A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects with Active Non infectious Uveitis | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Filgotinib in Subjects with Active Non infectious Uveitis | Gilead Sciences, Inc. | $61.05 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 18 | $2,358 | $624.88 |
| 2022 | 2 | 32 | 51 | $10,361 | $3,762 |
| 2021 | 1 | 12 | 19 | $4,560 | $1,710 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92134 | Imaging of retina | Office | 2023 | 12 | 18 | $2,358 | $624.88 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 20 | $6,300 | $2,683 | 42.6% |
| 92134 | Imaging of retina | Office | 2022 | 20 | 31 | $4,061 | $1,079 | 26.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 19 | $4,560 | $1,710 | 37.5% |
About Dr. Hatice Sen, MD
Dr. Hatice Sen, MD is a Ophthalmology healthcare provider based in Bethesda, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/04/2009. The National Provider Identifier (NPI) number assigned to this provider is 1871733733.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hatice Sen, MD has received a total of $82.84 in payments from pharmaceutical and medical device companies, with $21.79 received in 2023. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "" ($61.05).
As a Medicare-enrolled provider, Sen has provided services to 56 Medicare beneficiaries, totaling 88 services with total Medicare billing of $6,096. Data is available for 3 years (2021–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Bethesda, MD
- Active Since 03/04/2009
- Last Updated 03/04/2009
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1871733733
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Bethesda
Frederick Ferris, Md, MD
Ophthalmology — Payments: $63,291
Dr. Matthew Debiec, Md, MD
Ophthalmology — Payments: $36,604
Dr. Stephen Pappas, M.d, M.D
Ophthalmology — Payments: $8,633
Dr. James Heltzer, Md, MD
Ophthalmology — Payments: $5,634
Emily Morin, Md, MD
Ophthalmology — Payments: $5,014
Emily Chew
Ophthalmology — Payments: $4,833